LB PHARMACEUTICALS INC (LBRX)
Pharmaceutical Preparations
Latest Price
$43.04
TTM P/E
307.43
Normalized P/E
--
Div Yield
--
Book Value
11.38
P/B Ratio
3.78
Institutional Ownership
100.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Deep Track Capital, LP | 3.35M | $108.0M | 11.69% | -- | 2026-06-30 |
| BlackRock, Inc. | 2.73M | $88.0M | 9.53% | +263.5K | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 2.21M | $71.0M | 7.70% | -- | 2026-06-30 |
| Trails Edge Capital Partners, LP | 1.52M | $49.0M | 5.31% | +203.7K | 2026-06-30 |
| Commodore Capital LP | 1.50M | $48.0M | 5.23% | -- | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.50M | $48.0M | 5.22% | -114.2K | 2026-06-30 |
| TCG Crossover Management, LLC | 1.45M | $46.0M | 5.05% | -392.2K | 2026-06-30 |
| Caligan Partners LP | 1.44M | $46.0M | 5.01% | -- | 2026-06-30 |
| Spruce Street Capital LP | 1.38M | $44.0M | 4.80% | -- | 2026-06-30 |
| Nantahala Capital Management, LLC | 1.05M | $34.0M | 3.67% | -- | 2026-06-30 |